US Patent 6861509 Antibodies to Ret and RetL3
Patent 6861509 was granted and assigned to Biogen on March, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+214 characters)
Article
Patent abstract
Nucleotide and amino acid sequences are provided for compounds which promote tissue growth, as well as methods for modulating tissue growth, for imaging tissues and organs, and for treating patients.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Catherine Hession0
Dane S. Worley0
Michele Sanicola-Nadel0
Richard L. Cate0
Date of Patent
March 1, 2005
0Patent Application Number
094894070
Date Filed
January 21, 2000
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6861509 Antibodies to Ret and RetL3
Find more entities like US Patent 6861509 Antibodies to Ret and RetL3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
